• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄激素受体启动子CpG岛的甲基化与前列腺癌细胞中雄激素受体表达的丧失有关。

Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells.

作者信息

Jarrard D F, Kinoshita H, Shi Y, Sandefur C, Hoff D, Meisner L F, Chang C, Herman J G, Isaacs W B, Nassif N

机构信息

Department of Surgery, University of Wisconsin Medical School, University of Wisconsin Comprehensive Cancer Center, Madison 53792, USA.

出版信息

Cancer Res. 1998 Dec 1;58(23):5310-4.

PMID:9850055
Abstract

Androgen-independent metastatic prostate cancer is characterized by a heterogeneous loss of androgen receptor (AR) expression among tumor cells. In this study, we evaluate DNA hypermethylation as a potential transcriptional regulatory mechanism in AR-negative prostate cancer cell lines. Nucleotide sequence analysis demonstrates an approximately 15-kb CpG island in the AR gene that encompasses the transcription start site and exon 1. Using Southern blotting with methylation-sensitive restriction enzymes and methylation-specific PCR, we find aberrant methylation in the AR expression-negative cell lines Du145, DuPro, TSU-PR1, and PPC1. Incomplete methylation in the AR CpG island is also seen in normal female breast and ovarian tissues consistent with the inactivation of one X chromosome by hypermethylation. In contrast, prostate cancer cell lines LNCaP and PC3 express AR and are unmethylated. Normal prostate epithelial cell strains demonstrate no methylation. Exposure of AR-negative prostate cancer cell lines to 5-aza-2' deoxycytidine, a demethylating agent, induces the reexpression of AR RNA in DuPro and TSU-PR1. This reexpression is associated with a demethylation of this region. Prostate-specific antigen, an androgen-responsive gene, is also specifically induced in these lines after AR reexpression. Therefore, in vitro DNA methylation of the 5' CpG AR island may be associated with the loss of AR expression. Furthermore, our results demonstrate that treatment with demethylating agents may engender the reexpression and function of the androgen receptor in AR-negative cell lines.

摘要

雄激素非依赖性转移性前列腺癌的特征是肿瘤细胞之间雄激素受体(AR)表达的异质性缺失。在本研究中,我们评估DNA高甲基化作为AR阴性前列腺癌细胞系中一种潜在转录调控机制的可能性。核苷酸序列分析显示AR基因中有一个约15 kb的CpG岛,其包含转录起始位点和外显子1。使用对甲基化敏感的限制性内切酶进行Southern印迹分析以及甲基化特异性PCR,我们发现在AR表达阴性的细胞系Du145、DuPro、TSU-PR1和PPC1中存在异常甲基化。在正常女性乳腺和卵巢组织中也可见AR CpG岛的不完全甲基化,这与一条X染色体通过高甲基化失活一致。相比之下,前列腺癌细胞系LNCaP和PC3表达AR且未发生甲基化。正常前列腺上皮细胞株未显示甲基化。将AR阴性前列腺癌细胞系暴露于脱甲基剂5-氮杂-2'-脱氧胞苷后,可诱导DuPro和TSU-PR1中AR RNA的重新表达。这种重新表达与该区域的去甲基化有关。雄激素反应性基因前列腺特异性抗原在AR重新表达后也在这些细胞系中被特异性诱导。因此,5' CpG AR岛的体外DNA甲基化可能与AR表达缺失有关。此外,我们的结果表明,用脱甲基剂处理可能会使AR阴性细胞系中的雄激素受体重新表达并发挥功能。

相似文献

1
Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells.雄激素受体启动子CpG岛的甲基化与前列腺癌细胞中雄激素受体表达的丧失有关。
Cancer Res. 1998 Dec 1;58(23):5310-4.
2
DNA methylation in the androgen receptor gene promoter region in rat prostate cancers.大鼠前列腺癌雄激素受体基因启动子区域的DNA甲基化
Prostate. 2002 Jun 1;52(1):82-8. doi: 10.1002/pros.10099.
3
Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer.雄激素受体最小启动子的甲基化使人类前列腺癌中的转录沉默。
Cancer Res. 2000 Jul 1;60(13):3623-30.
4
DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.DNA甲基化模式转变:非典型启动子高甲基化导致前列腺上皮内瘤变和前列腺癌中15-脂氧合酶-1上调。
Prostaglandins Other Lipid Mediat. 2007 Jan;82(1-4):185-97. doi: 10.1016/j.prostaglandins.2006.05.015. Epub 2006 Jul 11.
5
Androgen receptor expression in androgen-independent prostate cancer cell lines.
Prostate. 2001 Apr;47(1):66-75. doi: 10.1002/pros.1048.
6
Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.威尔姆斯肿瘤抑制基因WT1对雄激素信号通路的转录调控。
Anticancer Res. 2001 Jan-Feb;21(1A):1-10.
7
p21WAF1/CIP1 gene is inactivated in metastatic prostatic cancer cell lines by promoter methylation.p21WAF1/CIP1基因在转移性前列腺癌细胞系中因启动子甲基化而失活。
Prostate Cancer Prostatic Dis. 2005;8(4):321-6. doi: 10.1038/sj.pcan.4500822.
8
Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.通过普鲁卡因胺处理使人类前列腺癌细胞中GSTP1 CpG岛高甲基化逆转并重新激活pi类谷胱甘肽S-转移酶(GSTP1)表达
Cancer Res. 2001 Dec 15;61(24):8611-6.
9
Methylation of the CD44 metastasis suppressor gene in human prostate cancer.人前列腺癌中CD44转移抑制基因的甲基化
Cancer Res. 1999 May 15;59(10):2329-31.
10
PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.PC3人前列腺癌细胞保留了雄激素受体发挥肿瘤抑制能力所需的共调节因子,而DU145人前列腺癌细胞则不然。
Prostate. 2006 Sep 1;66(12):1329-38. doi: 10.1002/pros.20483.

引用本文的文献

1
Reciprocal regulation between DNMT3A/3B and microRNAs miRs-299-3p/-30e is a causal factor for the downregulation of microRNAs targeting androgen receptor in prostate cancer.DNMT3A/3B与微小RNA miR-299-3p/-30e之间的相互调控是前列腺癌中靶向雄激素受体的微小RNA下调的一个因果因素。
Heliyon. 2025 Jan 23;11(3):e41948. doi: 10.1016/j.heliyon.2025.e41948. eCollection 2025 Feb 15.
2
Prostatic androgen receptor signaling shows an age-related and lobe-specific alteration in mice.前列腺雄激素受体信号传导在小鼠中表现出与年龄相关的叶特异性改变。
Sci Rep. 2024 Dec 5;14(1):30302. doi: 10.1038/s41598-024-79879-x.
3
Epigenetic (De)regulation in Prostate Cancer.
前列腺癌中的表观遗传(去)调控。
Cancer Treat Res. 2023;190:321-360. doi: 10.1007/978-3-031-45654-1_10.
4
Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer.靶向 RB1 缺陷和神经内分泌前列腺癌中的 DNA 甲基化和 B7-H3。
Sci Transl Med. 2023 Nov 15;15(722):eadf6732. doi: 10.1126/scitranslmed.adf6732.
5
Novel Insights on the Role of Epigenetics in Androgen Receptor's Expression in Prostate Cancer.表观遗传学在前列腺癌中雄激素受体表达中的作用的新见解。
Biomolecules. 2023 Oct 14;13(10):1526. doi: 10.3390/biom13101526.
6
Lineage plasticity and treatment resistance in prostate cancer: the intersection of genetics, epigenetics, and evolution.前列腺癌中的谱系可塑性和治疗耐药性:遗传学、表观遗传学和进化的交集。
Front Endocrinol (Lausanne). 2023 Jun 30;14:1191311. doi: 10.3389/fendo.2023.1191311. eCollection 2023.
7
Mechanistic Insights into Harmine-Mediated Inhibition of Human DNA Methyltransferases and Prostate Cancer Cell Growth.关于 harmine 介导的人源 DNA 甲基转移酶抑制作用及其对前列腺癌细胞生长影响的机制研究
ACS Chem Biol. 2023 Jun 16;18(6):1335-1350. doi: 10.1021/acschembio.3c00065. Epub 2023 May 15.
8
Anticancer Effects of Propolis Extracts Obtained with the Cold Separation Method on PC-3 and DU-145 Prostate Cancer Cell Lines.冷分离法获得的蜂胶提取物对 PC-3 和 DU-145 前列腺癌细胞系的抗癌作用。
Molecules. 2022 Nov 26;27(23):8245. doi: 10.3390/molecules27238245.
9
Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity.匹配患者活检的转录谱分析阐明了恩杂鲁胺诱导谱系可塑性的分子决定因素。
Nat Commun. 2022 Sep 15;13(1):5345. doi: 10.1038/s41467-022-32701-6.
10
The Role of Epigenetic Change in Therapy-Induced Neuroendocrine Prostate Cancer Lineage Plasticity.表观遗传变化在治疗诱导的神经内分泌前列腺癌谱系可塑性中的作用。
Front Endocrinol (Lausanne). 2022 Jul 14;13:926585. doi: 10.3389/fendo.2022.926585. eCollection 2022.